← Leaderboards
Danuta Szczesna-Cordary
University Of Miami School Of Medicine
$10,536,169
Attributed
$11,340,467
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,340,467 · 9
By mechanism
R01$10,554,082 · 6
R56$487,511 · 1
T32$289,022 · 1
P41$9,852 · 1
Top collaborators
- Julian Borejdo4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Hemant Ishwaran$7,590,639
- James Douglas Potter$13,046,459
Others in their field
Top investigators on “Myocardium”
- Lynn A Sleeper · New England Research Institutes, Inc.$41,686,119
- Piero Anversa · New York Medical College$37,744,132
- Walter J Koch · Duke University$32,189,425
- Deepak Srivastava · J. David Gladstone Institutes$25,431,561
- Jianyi Zhang · University Of Alabama At Birmingham$23,901,556
- Ju Chen · University Of California, San Diego$23,492,230
Research focus
MyocardiumMuscle ContractionMyosin AtpasePhenotypeCardiacSkinMolecularMutationMuscle FibersMuscleHeartTransgenic OrganismsMutantBaseLinkPapillary MuscleCardiac Muscle ContractionTransgenic MiceActinsRegulationIn VivoSarcomeresGenesLight
Grant awards (29)
Redefining The Role Of Myosin Essential Light Chain In Cardiac Muscle$383,750
R01 · FY2023 · HL · contact PI
Redefining The Role Of Myosin Essential Light Chain In Cardiac Muscle$383,750
R01 · FY2022 · HL · contact PI
Redefining The Role Of Myosin Essential Light Chain In Cardiac Muscle$383,750
R01 · FY2021 · HL · contact PI
Redefining The Role Of Myosin Essential Light Chain In Cardiac Muscle$383,750
R01 · FY2020 · HL · contact PI
The myosin light chain regulators of heart function$487,511
R56 · FY2019 · HL · contact PI
Novel cardioskeletal myopathy associated with MYL2$498,844
R01 · FY2018 · HL · contact PI
Novel cardioskeletal myopathy associated with MYL2$498,844
R01 · FY2017 · HL · contact PI
Novel cardioskeletal myopathy associated with MYL2$500,476
R01 · FY2016 · HL · contact PI
Novel cardioskeletal myopathy associated with MYL2$542,614
R01 · FY2015 · HL · contact PI
Myosin ELC, a novel therapeutic target for FHC$379,429
R01 · FY2015 · HL · contact PI
Myosin ELC, a novel therapeutic target for FHC$377,504
R01 · FY2014 · HL · contact PI
Myosin ELC, a novel therapeutic target for FHC$371,280
R01 · FY2013 · HL · contact PI
Myosin ELC, a novel therapeutic target for FHC$406,916
R01 · FY2012 · HL · contact PI
Single Cross-Bridge Kinetics in Transgenic Mouse Hearts Expressing FHC Mutations$396,397
R01 · FY2012 · HL
Functional Consequences of FHC-linked RLC Mutations.$383,943
R01 · FY2012 · HL · contact PI
Single Cross-Bridge Kinetics in Transgenic Mouse Hearts Expressing FHC Mutations$400,400
R01 · FY2011 · HL
Functional Consequences of FHC-linked RLC Mutations.$387,764
R01 · FY2011 · HL · contact PI
Cardiac Troponin in Health and Disease$382,500
R01 · FY2011 · HL · contact PI
Training Program in Cardiovascular Signaling$289,022
T32 · FY2011 · HL · contact PI
THE N-TERMINAL MYOSIN-ELC REGULATION OF CARDIAC MUSCLE CONTRACTION$9,852
P41 · FY2011 · RR · contact PI
Single Cross-Bridge Kinetics in Transgenic Mouse Hearts Expressing FHC Mutations$400,400
R01 · FY2010 · HL
Functional Consequences of FHC-linked RLC Mutations.$387,708
R01 · FY2010 · HL · contact PI
Single Cross-Bridge Kinetics in Transgenic Mouse Hearts Expressing FHC Mutations$411,400
R01 · FY2009 · HL
Functional Consequences of FHC-linked RLC Mutations.$387,654
R01 · FY2009 · HL · contact PI
Functional Consequences of FHC-linked RLC Mutations.$414,102
R01 · FY2008 · HL · contact PI
Functional Consequences of FHC-linked RLC Mutations$369,849
R01 · FY2006 · HL · contact PI
Functional Consequences of FHC-linked RLC Mutations$377,463
R01 · FY2005 · HL
Functional Consequences of FHC-linked RLC Mutations$376,175
R01 · FY2004 · HL
Functional Consequences of FHC-linked RLC Mutations$367,420
R01 · FY2003 · HL